Paul David C
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Paul David C. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| GMED | Executive Chairman | Option Exercise | 34,375 | $25.52 | $877,250 | Dec 8, 2025 |
| GMED | Executive Chairman | Option Exercise | 26,042 | $24.10 | $627,612 | Nov 15, 2024 |
| GMED | Executive Chairman | Sale | 298,647 | $54.01 | $16,129,924 | Sep 24, 2018 |
| GMED | Executive Chairman | Sale | 6,841 | $52.95 | $362,231 | Jul 17, 2018 |
| GMED | Executive Chairman | Option Exercise | 98,958 | $24.10 | $2,384,888 | Apr 26, 2018 |
| GMED | Chief Executive Officer | Sale | 1,427,079 | $25.00 | $35,676,975 | Mar 19, 2015 |
| GMED | Chief Executive Officer | C | 500,000 | — | — | Apr 15, 2014 |
| GMED | Chief Executive Officer | C | 500,000 | — | — | Mar 12, 2014 |
| GMED | Chief Executive Officer | C | 3,039,385 | — | — | Aug 8, 2012 |